Advertisement · 728 × 90
#
Hashtag
#SOPHiA_GENETICS
Advertisement · 728 × 90
Preview
SOPHiA GENETICS Announces Financial Performance for 2025; Revenue Up and Continued Growth in AI-Driven Precision Medicine SOPHiA GENETICS reports strong financial performance for the fourth quarter and full year 2025, showcasing revenue growth and business expansion opportunities in precision medicine.

SOPHiA GENETICS Announces Financial Performance for 2025; Revenue Up and Continued Growth in AI-Driven Precision Medicine #None #financial_report #SOPHiA_GENETICS #AI-driven_medicine

0 0 0 0
Preview
SOPHiA GENETICS Set to Shine at TD Cowen Health Care Conference in Boston SOPHiA GENETICS, a leading AI-driven company in precision medicine, will present at the TD Cowen annual Health Care Conference. Don't miss this event!

SOPHiA GENETICS Set to Shine at TD Cowen Health Care Conference in Boston #United_States #Boston #Health_Care #SOPHiA_GENETICS #AI-driven_medicine

0 0 0 0
Preview
SOPHiA GENETICS' Expansion in the U.S.: Transforming Healthcare with Two Leading Health Systems SOPHiA GENETICS strengthens its U.S. presence by partnering with two major health systems to leverage AI for genomic data analysis, enhancing precision medicine.

SOPHiA GENETICS' Expansion in the U.S.: Transforming Healthcare with Two Leading Health Systems #United_States #Boston #genomic_testing #SOPHiA_GENETICS #AI-driven_medicine

0 0 0 0
Preview
SOPHiA GENETICS Releases Preliminary Financial Results and Transitions Leadership for Future Growth SOPHiA GENETICS unveils strong preliminary financial performance for Q4 2025 and outlines guidance for 2026, including leadership transitions.

SOPHiA GENETICS Releases Preliminary Financial Results and Transitions Leadership for Future Growth #Boston #Switzerland #SOPHiA_GENETICS #Jurgi_Camblong #Ross_Muken

0 0 0 0
Preview
SOPHiA GENETICS Reports Positive Financial Progress for 2025 and Plans for 2026 SOPHiA GENETICS shares impressive preliminary results for Q4 2025 and full-year insights, projecting significant revenue growth for 2026 along with new leadership.

SOPHiA GENETICS Reports Positive Financial Progress for 2025 and Plans for 2026 #USA #Boston #SOPHiA_GENETICS #Ross_Muken #AI-driven_medicine

0 0 0 0
Preview
SOPHiA GENETICS Reveals Impressive Q4 Results and 2026 Forecast SOPHiA GENETICS announces strong preliminary Q4 results for 2025 and ambitious forecasts for 2026 while promoting new leadership.

SOPHiA GENETICS Reveals Impressive Q4 Results and 2026 Forecast #USA #Boston #SOPHiA_GENETICS #Jurgi_Camblong #Ross_Muken

0 0 0 0
Preview
SOPHiA GENETICS Reports Strong Q4 and 2025 Results, Announces 2026 Growth Guidance SOPHiA GENETICS shares its preliminary financial results for Q4 and 2025, revealing robust growth and a new CEO appointment for 2026.

SOPHiA GENETICS Reports Strong Q4 and 2025 Results, Announces 2026 Growth Guidance #USA #Boston #SOPHiA_GENETICS #AI_Precision_Medicine #Jurgi_Camblong

0 0 0 0
Preview
SOPHiA GENETICS Reports Preliminary Q4 2025 Financial Results and Management Changes SOPHiA GENETICS announces strong preliminary financial results for Q4 2025, forecasts for 2026 growth, and CEO transition plans. Discover the insights.

SOPHiA GENETICS Reports Preliminary Q4 2025 Financial Results and Management Changes #USA #Boston #financial_results #SOPHiA_GENETICS #AI_Precision_Medicine

0 0 0 0
Preview
SOPHiA GENETICS and MD Anderson Team Up for AI-Enhanced Cancer Treatment SOPHiA GENETICS announces a collaboration with MD Anderson to harness AI in enhancing precision oncology, setting a new standard in cancer care.

SOPHiA GENETICS and MD Anderson Team Up for AI-Enhanced Cancer Treatment #USA #Houston #MD_Anderson #Precision_Oncology #SOPHiA_GENETICS

0 0 0 0
Preview
Complete Genomics and SOPHiA GENETICS Collaborate for Advanced Oncology Testing Solutions in 2025 Complete Genomics collaborates with SOPHiA GENETICS to enhance precision oncology testing solutions. This partnership promises improved accessibility and quality in genomic profiling.

Complete Genomics and SOPHiA GENETICS Collaborate for Advanced Oncology Testing Solutions in 2025 #United_States #Boston #Complete_Genomics #SOPHiA_GENETICS #DNBSEQ-T1+

0 0 0 0
Preview
Complete Genomics and SOPHiA GENETICS Partner to Enhance Precision Medicine Through AI Analytics A groundbreaking collaboration between Complete Genomics and SOPHiA GENETICS aims to improve access to precision oncology testing using advanced AI-driven analytics.

Complete Genomics and SOPHiA GENETICS Partner to Enhance Precision Medicine Through AI Analytics #USA #Boston #Precision_Medicine #Complete_Genomics #SOPHiA_GENETICS

0 0 0 0
Preview
Collaboration Between SOPHiA GENETICS and Element Biosciences Enhances Precision Medicine Research SOPHiA GENETICS and Element Biosciences have teamed up to integrate AI with genomic sequencing, promising accelerated research in precision medicine.

Collaboration Between SOPHiA GENETICS and Element Biosciences Enhances Precision Medicine Research #USA #Boston #SOPHiA_GENETICS #Element_Biosciences #AVITI_system

0 0 0 0
Preview
A.D.A.M. Innovations and SOPHiA GENETICS Partner to Revolutionize Liquid Biopsy Testing in Japan A.D.A.M. Innovations collaborates with SOPHiA GENETICS to enhance liquid biopsy testing and precision oncology diagnostics in Japan's healthcare landscape.

A.D.A.M. Innovations and SOPHiA GENETICS Partner to Revolutionize Liquid Biopsy Testing in Japan #Japan #Tokyo #Precision_Oncology #SOPHiA_GENETICS #A.D.A.M._Innovations

0 0 0 0
Preview
A.D.A.M. Innovations and SOPHiA GENETICS Partner to Enhance Liquid Biopsy Testing in Japan A.D.A.M. Innovations and SOPHiA GENETICS are collaborating to promote liquid biopsy testing and companion diagnostics for precision oncology in Japan, enhancing patient care.

A.D.A.M. Innovations and SOPHiA GENETICS Partner to Enhance Liquid Biopsy Testing in Japan #Japan #Tokyo #Liquid_Biopsy #SOPHiA_GENETICS #ADAM_Innovations

1 0 0 0
Preview
A.D.A.M. Innovations and SOPHiA GENETICS Join Forces for Liquid Biopsy Innovation in Japan A.D.A.M. Innovations and SOPHiA GENETICS have collaborated to enhance liquid biopsy testing and diagnostics, aiming for precision oncology in Japan.

A.D.A.M. Innovations and SOPHiA GENETICS Join Forces for Liquid Biopsy Innovation in Japan #Japan #Tokyo #Precision_Oncology #SOPHiA_GENETICS #ADAM_Innovations

1 0 0 0
Preview
「SOPHiA GENETICS」と「ジェネシスヘルスケア」が手を組み、がん医療の未来を切り開く SOPHiA GENETICSとジェネシスヘルスケアが提携し、最先端のがんリキッドバイオプシーを日本に導入。個別化医療の普及を目指すこの革新に迫ります。

「SOPHiA GENETICS」と「ジェネシスヘルスケア」が手を組み、がん医療の未来を切り開く #東京都 #がん医療 #ジェネシスヘルスケア #SOPHiA_GENETICS

SOPHiA GENETICSとジェネシスヘルスケアが提携し、最先端のがんリキッドバイオプシーを日本に導入。個別化医療の普及を目指すこの革新に迫ります。

0 0 0 0
Preview
A.D.A.M. Innovations and SOPHiA GENETICS Unite to Revolutionize Liquid Biopsy Testing in Japan A.D.A.M. Innovations and SOPHiA GENETICS collaborate to enhance liquid biopsy testing and precision oncology in Japan, making advanced diagnostics accessible.

A.D.A.M. Innovations and SOPHiA GENETICS Unite to Revolutionize Liquid Biopsy Testing in Japan #Japan #Tokyo #Liquid_Biopsy #SOPHiA_GENETICS #ADAM_Innovations

0 0 0 0
Preview
Advancing Precision Oncology: A.D.A.M. Innovations Teams Up with SOPHiA GENETICS for Liquid Biopsy Testing A.D.A.M. Innovations and SOPHiA GENETICS join forces to enhance liquid biopsy testing for personalized cancer care in Japan, utilizing advanced AI technology.

Advancing Precision Oncology: A.D.A.M. Innovations Teams Up with SOPHiA GENETICS for Liquid Biopsy Testing #Japan #Tokyo #Liquid_Biopsy #SOPHiA_GENETICS #A.D.A.M._Innovations

1 0 0 0
Preview
SOPHiA GENETICS Launches Revolutionary AI-Powered Digital Twins for Oncology Decision-Making SOPHiA GENETICS introduces SOPHiA DDM™ Digital Twins, a groundbreaking AI technology aimed at aiding oncologists in making informed treatment decisions by simulating individual patient outcomes.

SOPHiA GENETICS Launches Revolutionary AI-Powered Digital Twins for Oncology Decision-Making #oncology #Digital_Twins #SOPHiA_GENETICS

0 0 0 0
Preview
Myriad Genetics and SOPHiA GENETICS Collaborate on Liquid Biopsy Diagnostics Myriad Genetics partners with SOPHiA GENETICS to create a groundbreaking liquid biopsy companion diagnostic test, enhancing cancer care worldwide.

Myriad Genetics and SOPHiA GENETICS Collaborate on Liquid Biopsy Diagnostics #USA #Liquid_Biopsy #Salt_Lake_City #SOPHiA_GENETICS #Myriad_Genetics

0 0 0 0
Preview
SOPHiA GENETICS Enhances Cancer Detection Collaboration with AstraZeneca SOPHiA GENETICS has partnered with AstraZeneca to improve breast and prostate cancer detection through advanced AI-driven genomic analysis solutions.

SOPHiA GENETICS Enhances Cancer Detection Collaboration with AstraZeneca #USA #Boston #AstraZeneca #Precision_Medicine #SOPHiA_GENETICS

0 0 0 0
Preview
SOPHiA GENETICS and Jessa Ziekenhuis Join Forces to Enhance Precision Oncology in Belgium A landmark partnership between SOPHiA GENETICS and Jessa Ziekenhuis aims to revolutionize precision oncology. This collaboration will enhance genomic testing for cancer patients across Belgium.

SOPHiA GENETICS and Jessa Ziekenhuis Join Forces to Enhance Precision Oncology in Belgium #Belgium #Precision_Oncology #SOPHiA_GENETICS #Jessa_Ziekenhuis #Hasselt

0 0 0 0
Preview
SOPHiA GENETICS Partners with Jessa Hospital for Precision Oncology Advances SOPHiA GENETICS and Jessa Hospital collaborate to enhance precision oncology in Belgium, utilizing cutting-edge genomics technology.

SOPHiA GENETICS Partners with Jessa Hospital for Precision Oncology Advances #Belgium #SOPHiA_GENETICS #Genomics_Technology #Hasselt #Jessa_Hospital

0 0 0 0
Preview
SOPHiA GENETICS and Jessa Ziekenhuis Unite for Advanced Cancer Care SOPHiA GENETICS and Jessa Ziekenhuis have launched a collaborative effort to enhance precision oncology, utilizing advanced genomic testing for cancer care in Belgium.

SOPHiA GENETICS and Jessa Ziekenhuis Unite for Advanced Cancer Care #oncology #Belgium #SOPHiA_GENETICS #Jessa_Ziekenhuis #Hasselt

0 0 0 0
Preview
SOPHiA GENETICS and Jessa Ziekenhuis to Revolutionize Cancer Care through Precision Oncology Partnership SOPHiA GENETICS partners with Jessa Ziekenhuis, enhancing genomic testing for cancer patients in Belgium. This collaboration aims to transform oncology care through data-driven technology.

SOPHiA GENETICS and Jessa Ziekenhuis to Revolutionize Cancer Care through Precision Oncology Partnership #oncology #Belgium #SOPHiA_GENETICS #Jessa_Ziekenhuis #Hasselt

0 0 0 0
Preview
SOPHiA GENETICS and Jessa Ziekenhuis Join Forces for Advanced Oncology Research SOPHiA GENETICS partners with Jessa Ziekenhuis to enhance cancer care through advanced genomic testing, streamlining operations and improving patient outcomes.

SOPHiA GENETICS and Jessa Ziekenhuis Join Forces for Advanced Oncology Research #Belgium #genomic_testing #SOPHiA_GENETICS #Jessa_Ziekenhuis #Hasselt

0 0 0 0
Preview
Enhancing Breast Cancer Treatments Through AI: A New Partnership between SOPHiA GENETICS and AstraZeneca SOPHiA GENETICS teams up with AstraZeneca to harness AI's potential in improving breast cancer outcomes. This partnership aims to revolutionize patient care.

Enhancing Breast Cancer Treatments Through AI: A New Partnership between SOPHiA GENETICS and AstraZeneca #USA #Boston #AstraZeneca #Breast_Cancer #SOPHiA_GENETICS

0 0 0 0
Preview
SOPHiA GENETICS Reveals Impressive Financial Performance for Q2 2025 SOPHiA GENETICS announces robust Q2 2025 financial results, showcasing a 16% revenue increase and strategic partnerships solidifying its market position.

SOPHiA GENETICS Reveals Impressive Financial Performance for Q2 2025 #None #SOPHiA_GENETICS #MSK-ACCESS #AI_oncology

0 0 0 0
Preview
SOPHiA GENETICS Declares Impressive Q1 2025 Financial Results Amid Growing Demand SOPHiA GENETICS, a cloud-native software leader, reports a 13% revenue increase in Q1 2025, showcasing broad market appeal and operational improvement.

SOPHiA GENETICS Declares Impressive Q1 2025 Financial Results Amid Growing Demand #USA #Boston #SOPHiA_GENETICS #data-driven_medicine #SOPHiA_DDM

0 0 0 0
Preview
SOPHiA GENETICS Expands Global Liquid Biopsy Testing Collaboration with AstraZeneca SOPHiA GENETICS and AstraZeneca deepen their partnership to enhance global liquid biopsy testing. The expansion targets 30 clinical sites in 2025.

SOPHiA GENETICS Expands Global Liquid Biopsy Testing Collaboration with AstraZeneca #USA #Boston #AstraZeneca #SOPHiA_GENETICS #MSK-ACCESS

0 0 0 0